scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P50 | author | B. C. J. M. Fauser | Q112562991 |
P2093 | author name string | Eijkemans MJ | |
Visser GH | |||
Hughes EG | |||
Macklon NS | |||
Boomsma CM | |||
P433 | issue | 6 | |
P921 | main subject | human pregnancy | Q11995 |
polycystic ovary syndrome | Q500816 | ||
meta-analysis | Q815382 | ||
polycystic ovary | Q5547896 | ||
P304 | page(s) | 673-683 | |
P577 | publication date | 2006-08-04 | |
P1433 | published in | Human Reproduction Update | Q15724523 |
P1476 | title | A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome | |
P478 | volume | 12 |
Q92188420 | A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome |
Q38371865 | A comprehensive approach in diagnosing the polycystic ovary syndrome |
Q45111540 | A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis |
Q47578433 | A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome |
Q46491999 | Abnormal Placentation Associated with Infertility as a Marker of Overall Health |
Q35737821 | Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment |
Q35767806 | Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study |
Q64107820 | Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally |
Q54312191 | Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome. |
Q47629555 | Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? |
Q38812465 | Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life? |
Q37396144 | Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults |
Q38001860 | Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review |
Q33736117 | Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. |
Q34910971 | Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia |
Q35137230 | Birth weight and childhood growth in daughters of women with irregular menstrual cycles |
Q34396231 | Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). |
Q38297114 | British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice |
Q29248890 | CLINICAL PRACTICE. Polycystic Ovary Syndrome |
Q35589236 | Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia |
Q39133343 | Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. |
Q92194284 | Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis |
Q50102650 | Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort |
Q34258370 | Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes |
Q92331086 | Child Health: Is It Really Assisted Reproductive Technology that We Need to Be Concerned About? |
Q24235484 | Chinese herbal medicine for subfertile women with polycystic ovarian syndrome |
Q24240718 | Chinese herbal medicine for subfertile women with polycystic ovarian syndrome |
Q38376246 | Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. |
Q36406468 | Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial |
Q80832590 | Clomiphene citrate: an old favourite lives on |
Q36161784 | Co-morbidity of cervical incompetence with polycystic ovarian syndrome (PCOS) negatively impacts prognosis: A retrospective analysis of 178 patients. |
Q37226664 | Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study |
Q89625695 | Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT |
Q60937952 | Comparison of uterine and ovarian stromal blood flow in patients with polycystic ovarian syndrome |
Q26799566 | Complications and challenges associated with polycystic ovary syndrome: current perspectives |
Q37965510 | Consensus on women's health aspects of polycystic ovary syndrome (PCOS). |
Q36935506 | Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study. |
Q46608748 | Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity |
Q36812563 | Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome |
Q44193673 | Contribution of method of conception on pregnancy outcome after the 11-13 weeks scan |
Q35177925 | Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study |
Q37939291 | Current perspectives of insulin resistance and polycystic ovary syndrome |
Q37230319 | Current trends in the treatment of polycystic ovary syndrome with desire for children |
Q90801248 | Curtailing PCOS |
Q34129292 | Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome |
Q35763642 | Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep |
Q48282250 | Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study |
Q33587845 | Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline |
Q90725281 | Disordered Eating Behaviours and Eating Disorders in Women in Australia with and without Polycystic Ovary Syndrome: A Cross-Sectional Study |
Q39177630 | Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome? |
Q34603981 | Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? |
Q57910457 | Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes? |
Q37118473 | Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal |
Q92967176 | Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study |
Q50212287 | Effect of GnRHR polymorphisms on in vitro fertilization and embryo transfer in patients with polycystic ovary syndrome |
Q28834175 | Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome |
Q62538125 | Effect of Type 2 Diabetes Mellitus on the Pharmacokinetics of Metformin in Obese Pregnant Women |
Q37042367 | Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome |
Q38660078 | Effect of maternal PCOS and PCOS-like phenotype on the offspring's health |
Q26991523 | Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis |
Q36923352 | Effectiveness of electroacupuncture for polycystic ovary syndrome: study protocol for a randomized controlled trial. |
Q39041432 | Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome. |
Q38063567 | Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials |
Q37256835 | Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis |
Q46335947 | Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study |
Q38600177 | Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis |
Q92956492 | Environmental Toxins and Infertility |
Q38007200 | Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome |
Q37764927 | Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature. |
Q34305184 | Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring |
Q37663309 | Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran |
Q48686680 | Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates |
Q34041888 | Fetal programming and metabolic syndrome |
Q46371543 | Free radical scavenging window of infertile patients with polycystic ovary syndrome: correlation with embryo quality |
Q24289192 | Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response |
Q28291029 | Genetic variants and the risk of gestational diabetes mellitus: a systematic review |
Q37049974 | Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. |
Q26740034 | Genetic, hormonal and metabolic aspects of PCOS: an update |
Q39038193 | Gestational Hyperandrogenism in Developmental Programming |
Q44501348 | Group-based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community-based longitudinal study. |
Q35107945 | Growth development of French children born after in vitro maturation. |
Q46144968 | Haemoglobin, C-reactive protein and androgen levels in uncomplicated and complicated pregnancies of women with polycystic ovary syndrome |
Q35738257 | HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome |
Q27026624 | Health and fertility in World Health Organization group 2 anovulatory women |
Q42905796 | Hormonal and metabolic characteristics of premenopausal women with a history of preeclamptic pregnancy |
Q92003913 | How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice? |
Q36868187 | How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation |
Q36661975 | Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study |
Q24186095 | Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome |
Q24198844 | Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome |
Q33893011 | Identification and treatment of metabolic complications in pediatric obesity |
Q34099068 | Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis |
Q34604094 | Implication of SH2B1 gene polymorphism studies in gestational diabetes mellitus in Saudi pregnant women |
Q38011264 | In vitro fertilisation: perinatal risks and early childhood outcomes |
Q44119554 | In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes |
Q51363991 | Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study. |
Q33849481 | Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels |
Q38591258 | Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome |
Q50571045 | Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes. |
Q33569169 | Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications |
Q39026021 | Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies |
Q38626489 | Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age. |
Q36709715 | Intrauterine environment and polycystic ovary syndrome |
Q64101187 | Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice |
Q33617230 | Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri |
Q37429919 | Live birth rates and birth outcomes by diagnosis using linked cycles from the SART CORS database |
Q42282571 | Loss of Endometrial Sodium Glucose Cotransporter SGLT1 is Detrimental to Embryo Survival and Fetal Growth in Pregnancy. |
Q44243871 | Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome |
Q40680864 | Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions |
Q36429617 | Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction |
Q84888095 | Maternal obesity: the interplay between inflammation, mother and fetus |
Q52580412 | Maternal polycystic ovarian syndrome and early offspring development. |
Q88777815 | Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study |
Q37149626 | Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. |
Q40946230 | Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS) |
Q37412812 | Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. |
Q43166289 | Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome |
Q50056205 | Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis |
Q42868207 | Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study |
Q22242884 | Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications |
Q92324109 | Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression |
Q47112166 | Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis |
Q27000954 | Obesity and PCOS: implications for diagnosis and treatment |
Q26830536 | Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome |
Q37079215 | Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis |
Q46655583 | Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis. |
Q47857506 | Obstetrical complications in dichorionic twin pregnancies in women with polycystic ovary syndrome |
Q57458409 | Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome |
Q34673147 | Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration |
Q33990127 | Overweight and Obesity before, during and after Pregnancy: Part 1: Pathophysiology, Molecular Biology and Epigenetic Consequences |
Q38230280 | Oxidative stress in pregnancy and fertility pathologies |
Q61854954 | PCOS and Pregnancy: Impact of Endocrine and Metabolic Factors |
Q33816253 | PCOS--what matters in early pregnancy?--data from a cross-sectional, multicenter study |
Q30371644 | Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome. |
Q38851128 | Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics |
Q50280323 | Placental characteristics in women with polycystic ovary syndrome |
Q55395471 | Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review. |
Q80844876 | Polycystic ovary syndrome |
Q83062366 | Polycystic ovary syndrome |
Q88098767 | Polycystic ovary syndrome |
Q36935621 | Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles |
Q38654905 | Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome? |
Q37699367 | Polycystic ovary syndrome and weight management |
Q47915318 | Polycystic ovary syndrome throughout a woman's life |
Q37585306 | Polycystic ovary syndrome, obesity and reproductive implications |
Q38010787 | Polycystic ovary syndrome: a common but often unrecognized condition |
Q38218598 | Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about |
Q21245262 | Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan |
Q37832125 | Polycystic ovary syndrome: etiology, pathogenesis and diagnosis |
Q39667906 | Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes -- the PICOLO Study |
Q51005062 | Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats. |
Q41244068 | Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study |
Q38263893 | Pregnancy complications in polycystic ovary syndrome patients |
Q26822402 | Pregnancy complications in women with polycystic ovary syndrome |
Q36862243 | Pregnancy in polycystic ovary syndrome |
Q34257603 | Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview |
Q49959431 | Pregnancy-related outcomes for women with polycystic ovary syndrome |
Q36152304 | Prevalence of cervical insufficiency in polycystic ovarian syndrome |
Q44446725 | Prevalence of polycystic ovary syndrome in women in China: a large community-based study |
Q34575260 | Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration |
Q38365322 | ROLE OF INSULIN SENSITIZERS ON CARDIOVASCULAR RISK FACTORS IN POLYCYSTIC OVARIAN SYNDROME: A META-ANALYSIS. |
Q28383112 | Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome |
Q35815740 | Relationship between Polycystic Ovarian Syndrome and Subsequent Gestational Diabetes Mellitus: A Nationwide Population-Based Study |
Q56973886 | Reproductive endocrinology: Maternal and fetal insulin levels at birth in women with PCOS |
Q85230833 | Reproductive endocrinology: revisiting ovulation induction in PCOS |
Q33697865 | Risk factors for preeclampsia in infertile Chinese women with polycystic ovary syndrome: A prospective cohort study |
Q39937391 | Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population |
Q36731528 | Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome |
Q35340822 | Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study |
Q36604066 | Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome |
Q42820460 | Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome |
Q36329913 | Role of metformin in the management of polycystic ovary syndrome |
Q35049496 | Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history |
Q37413767 | Sex hormone binding globulin measurement before conception as a predictor of gestational diabetes in women with polycystic ovarian syndrome |
Q42859978 | Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome |
Q37906977 | Sex steroid hormones and reproductive disorders: impact on women's health |
Q47809914 | Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome |
Q36943683 | Targets to treat metabolic syndrome in polycystic ovary syndrome |
Q61453124 | The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort |
Q35100131 | The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus |
Q37924338 | The consequences of obesity and excess weight gain in pregnancy |
Q26784331 | The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol |
Q37326585 | The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review |
Q41204582 | The effects of polycystic ovary syndrome on gestational diabetes mellitus |
Q33580018 | The experience of women affected by polycystic ovary syndrome: a qualitative study from iran |
Q28396893 | The exposome--exciting opportunities for discoveries in reproductive and perinatal epidemiology |
Q38924361 | The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance |
Q38229280 | The management of patients with polycystic ovary syndrome |
Q62091537 | The ovarian dysgenesis syndrome |
Q35841226 | The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome |
Q50428675 | Therapeutic approach for metabolic disorders and infertility in women with PCOS. |
Q36273439 | Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice |
Q34574136 | Treatment options for polycystic ovary syndrome |
Q30847984 | Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis |
Q24234635 | Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women |
Q37769526 | Use of metformin in the treatment of polycystic ovary syndrome |
Q53742992 | Valuable predictors of gestational diabetes mellitus in infertile Chinese women with polycystic ovary syndrome: a prospective cohort study. |
Q41790078 | Weight Management Interventions in Women with and without PCOS: A Systematic Review |
Q83030389 | [Definitions, epidemiology, risk factors] |
Q51366656 | [Markers of diagnosis and treatment in 924 pregnancies with gestational diabetes mellitus]. |
Search more.